✦ LIBER ✦

The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM)

✍ Scribed by Basile, Jan N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug–Drug Interactions with Sodium-Gluco

✍ Scheen, AndrÃ© J. 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 324 KB

Ipragliflozin and other sodium–glucose c

✍ Kurosaki, Eiji; Ogasawara, Hideaki 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 719 KB

Novel l-Xylose Derivatives as Selective

✍ Goodwin, Nicole C.; Mabon, Ross; Harrison, Bryce A.; Shadoan, Melanie K.; Almste 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 762 KB

Discovery of Dapagliflozin: A Potent, Se

✍ Meng, Wei; Ellsworth, Bruce A.; Nirschl, Alexandra A.; McCann, Peggy J.; Patel, 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 203 KB

Efficacy and safety of empagliflozin, a

✍ Rosenstock, J.; Seman, L. J.; Jelaska, A.; Hantel, S.; Pinnetti, S.; Hach, T.; W 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

5a-Carba-β-d-glucopyranose derivatives a

✍ Yoshihito Ohtake; Tsutomu Sato; Hiroharu Matsuoka; Masahiro Nishimoto; Naoki Tak 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 658 KB